GOLDMAN SACHS GROUP INC - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,378,664
-53.6%
614,642
-28.5%
0.00%
-100.0%
Q2 2023$5,121,124
+60.4%
859,249
-12.0%
0.00%0.0%
Q1 2023$3,191,828
-56.7%
976,094
-47.6%
0.00%
-50.0%
Q4 2022$7,364,767
-13.0%
1,864,498
+32.2%
0.00%0.0%
Q3 2022$8,466,000
+54.7%
1,410,868
+65.8%
0.00%
+100.0%
Q2 2022$5,472,000
+11.3%
851,027
+43.0%
0.00%0.0%
Q1 2022$4,917,000
-18.5%
595,289
+52.8%
0.00%0.0%
Q4 2021$6,030,000
-2.0%
389,493
+42.5%
0.00%0.0%
Q3 2021$6,155,000
-14.9%
273,325
-25.7%
0.00%
-50.0%
Q2 2021$7,235,000
+37.9%
367,988
+134.7%
0.00%
+100.0%
Q1 2021$5,248,000156,7860.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$1,145,980,00018.35%
Trustees of Columbia University in the City of New York 281,250$9,414,00011.41%
Alphabet Inc. 2,812,500$94,134,0003.80%
Omega Fund Management, LLC 843,750$28,240,0002.67%
EMJ Capital Ltd. 200,000$6,694,0001.48%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,131,249$138,273,0000.89%
HARVARD MANAGEMENT CO INC 468,749$15,689,0000.88%
Dragoneer Investment Group 1,500,000$50,205,0000.72%
Avidity Partners Management LP 732,321$24,511,0000.68%
SB Management Ltd 2,625,153$87,864,0000.57%
View complete list of SANA BIOTECHNOLOGY INC shareholders